Flagship Ventures Fund IV General Partner LLC Insider Trading $KLDO Kaleido Biosciences, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Flagship Ventures Fund IV General Partner LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Flagship Ventures Fund IV General Partner LLC. Flagship Ventures Fund IV General Partner LLC is 10% Owner in Seres Therapeutics, Inc. ($MCRB) and 10% Owner in Axcella Health Inc. ($AXLA) and Director in Moderna, Inc. ($MRNA) and 10% Owner in Evelo Biosciences, Inc. ($EVLO) and 10% Owner in Rubius Therapeutics, Inc. ($RUBY) and Director in Rubius Therapeutics, Inc. ($RUBY) and 10% Owner in Kaleido Biosciences, Inc. ($KLDO) and Director in Kaleido Biosciences, Inc. ($KLDO) and 10% Owner in TransMedics Group, Inc. ($TMDX).

Flagship Ventures Fund IV General Partner LLC in Kaleido Biosciences, Inc.

Trading Symbol: KLDO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner, Director
Holdings: 1,685,444 shares
Latest Transaction: Feb 10 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Flagship Ventures Fund IV General Partner LLC in Kaleido Biosciences, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AXLA, EVLO, KLDO, MRNA, RUBY, MCRB, TMDX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 10 2021	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	11.50	71,667	824,171	738,333	666.7 K to 738.3 K (+10.75 %)
Feb 10 2021	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	11.50	71,667	824,171	2,982,639	2.9 M to 3 M (+2.46 %)
Feb 10 2021	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	11.50	71,666	824,159	1,685,444	1.6 M to 1.7 M (+4.44 %)
Jun 08 2020	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	7.50	666,666	4,999,995	666,666	0 to 666.7 K
Jun 08 2020	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	7.50	666,667	5,000,003	2,910,972	2.2 M to 2.9 M (+29.70 %)
Jun 08 2020	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	7.50	666,667	5,000,003	1,613,778	947.1 K to 1.6 M (+70.39 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	562,407	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	347,173	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	1,331,816	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	281,203	0	947,111	665.9 K to 947.1 K (+42.23 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	173,586	0	216,451	42.9 K to 216.5 K (+404.96 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	665,908	0	665,908	0 to 665.9 K
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	562,407	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	347,173	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	1,331,816	0	0
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	281,203	0	947,111	665.9 K to 947.1 K (+42.23 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	173,586	0	216,451	42.9 K to 216.5 K (+404.96 %)
Mar 06 2019	KLDO	Kaleido Bioscience ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	665,908	0	665,908	0 to 665.9 K

Page: 1